JP2003511396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003511396A5 JP2003511396A5 JP2001529267A JP2001529267A JP2003511396A5 JP 2003511396 A5 JP2003511396 A5 JP 2003511396A5 JP 2001529267 A JP2001529267 A JP 2001529267A JP 2001529267 A JP2001529267 A JP 2001529267A JP 2003511396 A5 JP2003511396 A5 JP 2003511396A5
- Authority
- JP
- Japan
- Prior art keywords
- chemotherapeutic agent
- pharmaceutical composition
- formula
- composition according
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002246 antineoplastic agent Substances 0.000 description 25
- 229940127089 cytotoxic agent Drugs 0.000 description 24
- 239000008194 pharmaceutical composition Substances 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 10
- 229940123237 Taxane Drugs 0.000 description 9
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 6
- 229930012538 Paclitaxel Natural products 0.000 description 5
- 229960001592 paclitaxel Drugs 0.000 description 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 5
- 229930192392 Mitomycin Natural products 0.000 description 3
- 229940122803 Vinca alkaloid Drugs 0.000 description 3
- 229940045799 anthracyclines and related substance Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- RSJCLODJSVZNQA-BQYQJAHWSA-N CCOC/C=C/c(cc1)ccc1-c1nc(-c(cc2)ccc2NC(C)C)c(-c(cc2)ccc2NC(C)C)[nH]1 Chemical compound CCOC/C=C/c(cc1)ccc1-c1nc(-c(cc2)ccc2NC(C)C)c(-c(cc2)ccc2NC(C)C)[nH]1 RSJCLODJSVZNQA-BQYQJAHWSA-N 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15832299P | 1999-10-08 | 1999-10-08 | |
| US60/158,322 | 1999-10-08 | ||
| PCT/US2000/027612 WO2001026467A1 (en) | 1999-10-08 | 2000-10-06 | Methods of enhancing chemotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003511396A JP2003511396A (ja) | 2003-03-25 |
| JP2003511396A5 true JP2003511396A5 (https=) | 2006-01-05 |
Family
ID=22567591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001529267A Pending JP2003511396A (ja) | 1999-10-08 | 2000-10-06 | 化学療法を増強する方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP1221847B1 (https=) |
| JP (1) | JP2003511396A (https=) |
| AT (1) | ATE426335T1 (https=) |
| AU (1) | AU782401B2 (https=) |
| CA (1) | CA2382727A1 (https=) |
| DE (1) | DE60041880D1 (https=) |
| WO (1) | WO2001026467A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7888341B2 (en) | 2002-04-10 | 2011-02-15 | The United States Of America As Represented By The Department Of Veterans Affairs | Combination of glivec (STI571) with a cyclin-dependent kinase inhibitor, especially flavopiridol, in the treatment of cancer |
| CN101870691A (zh) | 2002-08-19 | 2010-10-27 | 劳洛斯治疗公司 | 2,4,5-三取代的咪唑及其作为抗菌剂的用途 |
| CA2545942C (en) | 2003-11-14 | 2012-07-10 | Lorus Therapeutics Inc. | Aryl imidazoles and their use as anti-cancer agents |
| AU2006250809B2 (en) | 2005-05-25 | 2011-05-12 | Lorus Therapeutics Inc. | 2-indolyl imidazo(4,5-D)phenanthroline derivatives and their use in the treatment of cancer |
| PL2454943T3 (pl) | 2010-11-23 | 2020-11-16 | Gea Food Solutions Bakel B.V. | Urządzenie i sposób do wytwarzania produktu z separatorem |
| KR20160042811A (ko) | 2013-03-20 | 2016-04-20 | 압토스 바이오사이언시스 인코포레이티드 | 2-치환 이미다조[4,5-d]페난쓰롤린 유도체 및 암 치료에 있어서의 이의 용도 |
| WO2015051304A1 (en) | 2013-10-04 | 2015-04-09 | Aptose Biosciences Inc. | Compositions, biomarkers and their use in treatment of cancer |
| WO2018154064A1 (en) | 2017-02-24 | 2018-08-30 | Bioactor Bv | Flavanones for use in treating visceral hypersensitivity |
| WO2019089511A1 (en) | 2017-10-30 | 2019-05-09 | Aptose Biosciences Inc. | Aryl imidazoles for the treatment of cancer |
| WO2022249192A1 (en) * | 2021-05-27 | 2022-12-01 | Ramot At Tel-Aviv University Ltd. | Broad-spectrum metastasis suppressing compounds and therapeutic uses thereof in human tumors |
| WO2025119974A1 (en) | 2023-12-04 | 2025-06-12 | Bioactor Bv | Naringin or naringenin for improving sleep quality |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US5756527A (en) * | 1995-06-07 | 1998-05-26 | Ontogen Corporation | Imidazole derivatives useful as modulators of multi drug resistances |
| US5700826A (en) | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
| US5840721A (en) * | 1997-07-09 | 1998-11-24 | Ontogen Corporation | Imidazole derivatives as MDR modulators |
-
2000
- 2000-10-06 JP JP2001529267A patent/JP2003511396A/ja active Pending
- 2000-10-06 EP EP00968797A patent/EP1221847B1/en not_active Expired - Lifetime
- 2000-10-06 EP EP09004137A patent/EP2064951A1/en not_active Withdrawn
- 2000-10-06 DE DE60041880T patent/DE60041880D1/de not_active Expired - Lifetime
- 2000-10-06 AT AT00968797T patent/ATE426335T1/de not_active IP Right Cessation
- 2000-10-06 WO PCT/US2000/027612 patent/WO2001026467A1/en not_active Ceased
- 2000-10-06 CA CA002382727A patent/CA2382727A1/en not_active Abandoned
- 2000-10-06 AU AU78661/00A patent/AU782401B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2470016C2 (ru) | Производное бипиразола | |
| JP2005515966A5 (https=) | ||
| WO2004043389B1 (en) | Methods of treating cancer and related methods | |
| JP2007507538A5 (https=) | ||
| ES2089027T3 (es) | Forma de dosificacion transmucosica. | |
| JP2009102342A5 (https=) | ||
| JP2005515996A5 (https=) | ||
| RU98111594A (ru) | Фармацевтические композиции, включающие флурбипрофен | |
| EP2482816A1 (en) | Topical compositions of opioid antagonists and methods for treating skin conditions therewith | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| JP2003511396A5 (https=) | ||
| JP2006512324A5 (https=) | ||
| JP2011500781A5 (https=) | ||
| CA2648518A1 (en) | Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor | |
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| ATE398441T1 (de) | Octenidinhaltige lutschtabletten gegen entzündliche erkrankungen des mund- und rachenraums | |
| US8664268B2 (en) | Gallium compositions for the treatment of liver cancer and methods of use | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| RU2018130097A (ru) | Лечение экземы кистей | |
| RU2016110546A (ru) | Комбинированная лекарственная терапия | |
| RU2002129298A (ru) | Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера | |
| JPH0840903A (ja) | 抗癌剤により誘発される末梢神経障害を予防するための医薬組成物 | |
| JP2003523385A5 (https=) | ||
| RU2004108853A (ru) | Новые препараты и их применение |